[1]
“Redefining diabesity management: Tirzepatide’s role in improving cardiovascular outcomes”, J. Assoc. Clin. Endocrinol. Diabetol. Bangladesh, vol. 4, no. 20, p. S33, Oct. 2025, doi: 10.3329/jacedb.v4i20.84909.